ArticleAdvances in therapy2026

A 3-Year Post-Marketing Surveillance Study of EX-PRESS™ Glaucoma Filtration Device in Japanese Eyes.

Masaru Inatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.